RPM and AI-Powered Med Tech Lead This Week's Funding | StartUp Health Insights: Week of Sep 3, 2024

Investors are backing innovative solutions for remote patient care and surgical optimization. This week's funding highlights include virtual wards, AI-powered neurotech, and lifestyle wellness.

This week’s reported health innovation funding included:

Doccla, a London, UK-based provider of virtual ward and remote patient monitoring services, raised £35M ($45.8M) led by Lakestar, with participation from Elaia, General Catalyst, Bertelsmann Investments, and Speedinvest. <source>

Vesta Healthcare, a New York, NY-based tech-enabled clinical services company, received a $35M venture loan facility from Horizon Technology Finance. <source>

Segmed, a Palo Alto, CA-based provider of real-world imaging data for health innovation, raised $10.4M led by iGan Partners and Advocate Health, with participation from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund. <source>

Piramidal, a San Francisco, CA-based AI-powered neurotech startup, raised $6M led by Y Combinator, with participation from Adverb Ventures, Lionheart Ventures, and angel investors. <source>

eXeX, an Orlando, FL-based med tech company utilizing artificial intelligence and spatial computing to optimize surgical procedures, raised $5.8M from undisclosed investors. <source>

myBiometry, a Boston, MA-based platform to remotely monitor and manage patients with asthma, raised $5M from undisclosed investors. <source>

Nudj Health, a Pasadena, CA-based tech-enabled service helping integrate lifestyle wellness into patient care, raised $3M from undisclosed investors. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.


Call for Alzheimer’s Innovation

With support from the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures, we’ve launched a new global initiative created to develop a collaborative innovation community alongside leading companies, research teams, and stakeholders with a mission to accelerate progress in prevention, diagnosis, and management of Alzheimer’s disease and related dementias. Learn more and apply for an Alzheimer’s Moonshot Fellowship.

Follow us on social media for daily updates on Health Transformers: X (Twitter), LinkedIn, Facebook, and Instagram.

Previous
Previous

ALZpath Is Powering a New Wave of Blood-Based Alzheimer’s Tests

Next
Next

Esya Labs Is Putting a New Spin on Brain Health Diagnostics